Article PDF
References
Sasaki S, Dampney RAL : Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension 1990; 15: 274–283.
Muratani H, Averill DB, Ferrario CM : Effect of angiotensin II in ventrolaterall medulla of spontaneously hypertensive rats. Am J Physiol 1991; 260: R977–R984.
Ito S, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF : Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension 2002; 40: 552–559.
Ito S, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF : Ventrolateral medulla AT1 receptors support arterial pressure in Dahl salt-sensitive rats. Hypertension 2003; 41: 744–750.
Saxby BK, Harrington F, Wesnes KA, McKeith IG, Ford GA : Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology 2008; 70: 1858–1866.
Wang J, Ho L, Chen L, et al: Valsartan lowers brain betaamyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 2007; 117: 3393–3402.
Solomon SD, Wang D, Finn P, et al: Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2004; 110: 2180–2183.
Mochizuki S, Dahlöf B, Shimizu M, et al: Jikei Heart Study Group: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007; 369: 1431–1439.
Oshima N, Kumagai H, Onimaru H, et al: Monosynaptic excitatory connection from the rostral ventrolateral medulla to sympathetic preganglionic neurons revealed by simultaneous recordings. Hypertens Res 2008; 31: 1445–1454.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ito, S., Komatsu, K., Yajima, Y. et al. Renin-Angiotensin System in the Brain as a New Target of Antihypertensive Therapy. Hypertens Res 31, 1487–1488 (2008). https://doi.org/10.1291/hypres.31.1487
Received:
Issue date:
DOI: https://doi.org/10.1291/hypres.31.1487
Keywords
This article is cited by
-
Antihypertensive Therapies and Cognitive Function: a Review
Current Hypertension Reports (2015)
-
Renin–angiotensin–aldosterone system has a pivotal role in cognitive impairment
Hypertension Research (2013)
-
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension
Hypertension Research (2011)
